“With her years of experience and success as both an operating leader and investor in medical device start-up companies like NxThera, Jan Garfinkle has a deep understanding of what it takes to build a successful business. When the inevitable challenges arise at NxThera, Jan’s knowledge and experience, together with her thoughtful and disciplined approach, helps us in developing and implementing practical and effective solutions. I appreciate the fact that Jan consistently challenges me to think ‘big’ and know that I have the support necessary to help us achieve our goals.”
Bob Paulson
CEO
NXThera
George Dunbar
 |
George Dunbar , Venture PartnerGeorge Dunbar joined Arboretum Ventures in 2010 as a Venture Partner. George utilizes his extensive healthcare operating experience as the former CEO of a number of venture-backed healthcare companies to evaluate new investment opportunities in the diagnostics, life sciences tools and medical devices sectors. George currently serves as the Executive Chairman of Arboretum portfolio company Accuri Cytometers and is Chairman of the Board of Directors at Aastrom Biosciences.
Prior to joining Arboretum Ventures, George was most recently the President and CEO of Aastrom Biosciences, a publicly-traded, clinical development stage healthcare company based in Ann Arbor. Prior to Aastrom, Mr. Dunbar worked with several national venture capital firms, serving as the CEO of a number of early-stage life sciences companies, including Quantum Dot (acquired by Invitrogen) and Epic Therapeutics (acquired by Baxter Healthcare). He has also held senior positions in licensing, business development and marketing with The Ares-Serono Group and Amersham International.
George is a graduate of Auburn University, holding both a Master’s degree in Business Administration and an undergraduate degree in Electrical Engineering, and currently sits on the MBA Advisory Board of the College of Business at Auburn.
|
